Rosacea Through the Ages: a Timeline
When the National Rosacea Society was founded 25 years ago, very few Americans were aware of this chronic skin disorder, even though it’s now estimated to affect more than 16 million in the U.S. alone. Here is a timeline that traces the recorded history of rosacea in art, literature and medical texts up to the present:
1300s: Dr. Guy de Chauliac, a French surgeon living in the 14th century, wrote about “red lesions in the face, particularly on the nose and cheeks.” He called the condition “goutterose” (French for “pink droplet”) or “couperose” (now a common French term for rosacea).
1400s: Chaucer’s Canterbury Tales includes a character called the Summoner who suffered from a rosacea-like illness.
1500s: Treatments for rosacea at this time included the use of salves containing such ingredients as mercury, sulphur and bull’s blood. Other treatments included blood-letting in the arm, forehead and nose, as well as applying leeches on affected areas.
1590s: Bardolph, a character in Shakespeare’s Henry IV and other plays, has the red bulbous nose of rhinophyma, commonly known today as subtype 3 (phymatous) rosacea.
1812: A written reference to “acne rosacea” appears in an English medical text by Dr. Thomas Bateman, who noted, “The perfect cure of acne rosacea is, in fact, never accomplished.”
1900s: W.C. Fields was a prominent comedic actor in America, appearing in vaudeville shows, silent films and talkies. He was known for his signature red bulbous nose and red face owing to subtype 3 rosacea.
1989: An epidemiological study found that approximately 10 percent of Swedes had rosacea. These and later studies were extrapolated to estimate that around 5 percent of Americans — or 16 million — now suffer from the disorder.
1992: The National Rosacea Society was formed to raise awareness and provide public health information on this little-known medical condition.
2000: The NRS launched its Research Grants Program to encourage and support research into potential causes and other key aspects of rosacea that may lead to improvements in its treatment and potential prevention or cure. Since then, this patient-funded program has awarded more than $1.5 million in research grants to support a wide range of rosacea-related studies.
2002: The “Standard classification of rosacea” was published by the NRS Expert Committee on the Classification and Staging of Rosacea, providing universal criteria and terminology for research, diagnoses and communications on the disorder.1
2017: Today we now know quite a bit about the disease process of rosacea, and a growing range of medical therapies is now available for its specific signs and symptoms. Yet despite these advances, only an estimated 18 percent of those who suffer from rosacea are currently receiving medical treatment.
Wilkin J, Dahl M, Detmar M, Drake L, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002;46:584-587.
196 James St.
Barrington, IL 60010
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.